Fletcher EAK, Cordfunke RA, Nasi A, Törnqvist G, Valentijn RRPM, Bergqvist A, Westhrin M, Rasch W, Lindqvist F, Dillmann I, Lord M, Bouwman N, Neefjes JJ, Franken KLMC, McArdle S, Ahmad M, Johansson S, Ossendorp F, Haggman M, Lampinen M, Ullenhag G, Ladjevardi S, Leja-Jarblad J, Lilleby W, Drijfhout JWet al.(2025) Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement Mol Ther Oncol, 33(2), 200954 DOI 10.1016/j.omton.2025.200954, PubMed 40520577
Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Villafranca Iturre AE, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier Cet al.(2025) Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial Lancet Oncol, 26(6), 695-706 DOI 10.1016/S1470-2045(25)00197-4, PubMed 40339593
Schytte T, Knap MM, Kristiansen C, Appelt AL, Khalil A, Peucelle C, Lutz CM, Møller DS, Sande EPS, Sundby F, Persson G, Schmidt H, Land LH, Rogg L, Pøhl M, Lund MD, Nielsen M, Levin N, Hansen O, Thing RS, Borissova S, Halvorsen T, Nielsen TB, Hansen TS, Haakensen VDet al.(2025) Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial J Clin Oncol, 43(17), 1972-1983 DOI 10.1200/JCO-24-01386, PubMed 40249893